BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Z, Wang J, Yuan H, Liu L, Bu Y, Zhao M, Yang G, Feng J, Liu Y, Li J, He Q, Zhang X. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver. Biochem Biophys Res Commun 2020;527:76-82. [PMID: 32446394 DOI: 10.1016/j.bbrc.2020.04.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 He P, Zhang P, Fang Y, Han N, Yang W, Xia Z, Zhu Y, Zhang Z, Shen J. The role of HBV cccDNA in occult hepatitis B virus infection. Mol Cell Biochem 2023. [PMID: 36735210 DOI: 10.1007/s11010-023-04660-z] [Reference Citation Analysis]
2 Xiong F, Wang Q, Wu G, Liu W, Wang B, Chen Y. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow. Biomark Res 2022;10. [DOI: 10.1186/s40364-022-00415-y] [Reference Citation Analysis]
3 Wang XL, Meng ZQ, Xu CH, Meng DM. Relationship among the interferon α-receptor, signal transduction, and therapeutic effect in patients with hepatitis B infection. Asian J Surg 2021:S1015-9584(21)00726-0. [PMID: 34865957 DOI: 10.1016/j.asjsur.2021.11.028] [Reference Citation Analysis]